LeMaitre Vascular (LMAT)
(Delayed Data from NSDQ)
$89.26 USD
-1.87 (-2.05%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $89.47 +0.21 (0.24%) 7:58 PM ET
1-Strong Buy of 5 1
F Value C Growth D Momentum D VGM
Income Statements
Fiscal Year end for LeMaitre Vascular, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 193 | 162 | 154 | 129 | 117 |
Cost Of Goods | 66 | 57 | 53 | 45 | 37 |
Gross Profit | 127 | 105 | 101 | 85 | 80 |
Selling & Adminstrative & Depr. & Amort Expenses | 90 | 78 | 65 | 56 | 59 |
Income After Depreciation & Amortization | 37 | 27 | 36 | 29 | 21 |
Non-Operating Income | 3 | 1 | 0 | 0 | 1 |
Interest Expense | 0 | 0 | 2 | 1 | 0 |
Pretax Income | 39 | 27 | 34 | 27 | 22 |
Income Taxes | 9 | 7 | 7 | 6 | 4 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 30 | 21 | 27 | 21 | 18 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 30 | 21 | 27 | 21 | 18 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 46 | 36 | 47 | 37 | 27 |
Depreciation & Amortization (Cash Flow) | 10 | 9 | 11 | 8 | 5 |
Income After Depreciation & Amortization | 37 | 27 | 36 | 29 | 21 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 22.42 | 22.17 | 21.48 | 20.48 | 20.33 |
Diluted EPS Before Non-Recurring Items | 1.35 | 1.07 | 1.25 | 1.04 | 0.88 |
Diluted Net EPS (GAAP) | 1.34 | 0.93 | 1.25 | 1.04 | 0.88 |
Fiscal Year end for LeMaitre Vascular, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 55.85 | 53.48 | 48.88 | 47.41 | 50.12 |
Cost Of Goods | 17.38 | 16.81 | 15.62 | 16.60 | 18.03 |
Gross Profit | 38.47 | 36.67 | 33.26 | 30.82 | 32.09 |
SG&A, R&D, and Dept/Amort Expenses | 24.08 | 24.79 | 23.06 | 21.63 | 22.64 |
Income After SG&A, R&D, and Dept/Amort Expenses | 14.39 | 11.88 | 10.20 | 9.19 | 9.45 |
Non-Operating Income | 1.13 | 0.92 | 1.11 | 0.65 | 0.87 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | 15.51 | 12.80 | 11.31 | 9.83 | 10.32 |
Income Taxes | 3.68 | 2.91 | 2.85 | 2.32 | 2.22 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 11.83 | 9.89 | 8.46 | 7.50 | 8.10 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 11.83 | 9.89 | 8.46 | 7.50 | 8.10 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 22.73 | 22.57 | 22.46 | 22.48 | 22.45 |
Diluted EPS Before Non-Recurring Items | 0.52 | 0.44 | 0.38 | 0.33 | 0.37 |
Diluted Net EPS (GAAP) | 0.52 | 0.44 | 0.38 | 0.33 | 0.36 |